ORCID as entered in ROS

Select Publications
2024, 'Documented variation in inflammatory bowel disease care in Australasia : Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 183 - 184
,2024, 'Gut microbiota are associated with disease activity in patients with Crohn's disease and ulcerative colitis: baseline sequencing from the Australian IBD Microbiome study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 234 - 234
,2024, 'Healthier dietary intake is positively associated with disease activity and inflammation in Australian adults with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 319 - 319
,2024, 'Impaired health-related quality of life is associated with alterations in gut microbiota in patients with inflammatory bowel disease: baseline sequencing from the Australian IBD Microbiome study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 217 - 218
,2024, 'Intestinal ultrasound in immune checkpoint inhibitor-related colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 214 - 215
,2024, 'Longitudinal microbial dynamics in an Australian adult inflammatory bowel disease cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 209 - 210
,2024, 'Microbial signatures associated with inflammatory bowel disease in Australia: baseline sequencing from the Australian IBD Microbiome study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 216 - 217
,2024, 'Post operative recurrence and surgical outcomes following Crohn's ileocolic resections in Australia (PORSCIA study)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 248 - 249
,2024, 'Unique faecal microbial profiles in first degree relatives of inflammatory bowel disease patients', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 209 - 209
,2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A149 - A150, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.207
,2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Bone loss is common but under-screened in patients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 128 - 128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE', in Gastroenterology, Elsevier BV, Vol. 158, http://dx.doi.org/10.1016/s0016-5085(20)31872-2
,2019, 'Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 13, pp. S374 - S374, http://dx.doi.org/10.1093/ecco-jcc/jjy222.647
,